The global industry was valued at US$ 140.2 Bn in 2022 and is estimated to grow at a CAGR of 9.1% from 2023 to 2031, reaching US$ 303.1 Bn by the end of 2031. The anticancer drugs market is witnessing substantial expansion as the global burden of cancer continues to rise and healthcare systems increasingly prioritize advanced oncology treatments. The growing prevalence of various forms of...

The global industry was valued at US$ 1.6 Bn in 2022 and is estimated to grow at a CAGR of 6.8% from 2023 to 2031, reaching US$ 2.9 Bn by the end of 2031. The head and neck cancer market is witnessing significant growth due to the rising prevalence of cancer cases, increasing awareness regarding early diagnosis, and advancements in targeted therapies and immunotherapy treatments. Head and neck...

The increasing demand for oncology therapeutics market solutions, rising adoption of cancer treatment drugs, and rapid advancements in targeted cancer therapies are transforming the global cancer treatment landscape. With the growing prevalence of head and neck cancers, healthcare providers and pharmaceutical companies are focusing on developing innovative therapies...

Liquid biopsies are no longer limited to cancer diagnosis—their applications in oncology now span early detection, treatment monitoring, and minimal residual disease (MRD) tracking, making them indispensable tools for personalized care. By analyzing circulating tumor DNA (ctDNA) and other biomarkers in blood, these tests provide real-time insights into tumor behavior, enabling clinicians...

"Executive Summary Next-Generation Targeted Oncology Drug Market Size and Share Analysis Report CAGR Value The global Next-Generation Targeted Oncology Drug Market research report has incorporated the analysis of different factors that augment the market's growth. It has various sections that provide the scope of different segments and applications that can potentially influence the market...

The rapid evolution of cancer molecular diagnostics, increasing adoption of molecular diagnostics in oncology, and growing demand for precision oncology diagnostics are transforming cancer detection and treatment worldwide. Molecular diagnostic technologies enable healthcare professionals to identify genetic mutations, biomarkers, and tumor-specific molecular...

"In-Depth Study on Executive Summary Oral HER Pathway Targeted Drugs Market Size and Share CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The Oral HER Pathway Targeted Drugs Market report contains...

The U.S. AI in Oncology Market is witnessing remarkable growth as artificial intelligence (AI) becomes increasingly integrated into cancer diagnosis, treatment planning, drug discovery, and patient management. Healthcare providers, research institutions, pharmaceutical companies, and technology developers are leveraging AI-powered solutions to improve clinical decision-making, enhance...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...